Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

FREDUN PHARMACEUTICALS LTD.

NSE : NABSE : 539730ISIN CODE : INE194R01017Industry : Pharmaceuticals & DrugsHouse : Private

BSE950.60-14.5 (-1.5 %)

PREV CLOSE ( ) 965.10

OPEN PRICE ( ) 972.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 24352

TODAY'S LOW / HIGH ( )930.00 984.00

52 WK LOW / HIGH ( ) 635972

NSE

This Company is not listed in NSE

Quarters

Select year

( in Million)

Particulars

Mar 2025

Audited / UnAudited

UnAudited

Net Sales

1674.08

Total Expenditure

1501.56

PBIDT (Excl OI)

172.52

Other Income

Operating Profit

172.51

Interest

81.47

Exceptional Items

PBDT

91.04

Depreciation

18.4

Profit Before Tax

72.64

Tax

12.61

Provisions and contingencies

Profit After Tax

60.03

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

60.03

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

60.04

Equity Capital

47.22

Face Value (IN RS)

Reserves

Calculated EPS

12.71

Calculated EPS (Annualised)

50.85

No of Public Share Holdings

2411277

% of Public Share Holdings

51.07

PBIDTM% (Excl OI)

10.30

PBIDTM%

10.30

PBDTM%

5.43

PBTM%

4.33

PATM%

3.58

Notes

Risk Disclosures on Derivatives

Quarterly Results

FREDUN PHARMACEUTICALS LTD.